Corrigendum: Comparison of peripheral blood regulatory T cells and functional subsets between ocular and generalized myasthenia gravis

Corrigendum: Comparison of peripheral blood regulatory T cells and functional subsets between ocular and generalized myasthenia gravis

Bibliographic Details
Main Authors:	Jie Rao, Siyu Li, Xinyu Wang, Qi Cheng, Yu Ji, Wenwen Fu, Hui Huang, Ling Shi, Xiaorong Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Medicine
Subjects:	ocular myasthenia gravis regulatory T cell subset CD45RA Foxp3
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1235861/full

Similar Items

Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis
by: Jie Rao, et al.
Published: (2022-06-01)

Ocular myasthenia gravis and thymoma
by: Victor Alegre-Ituarte, et al.
Published: (2022-09-01)

New-onset ocular myasthenia gravis following SARS-CoV-2 infection
by: Prabrisha Banerjee, et al.
Published: (2023-01-01)

Preliminary study on the immunology pathogenesis of ocular myasthenia gravis in children
by: Li-Jun Zhou, et al.
Published: (2013-12-01)

Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases
by: Tarin A. Europa, et al.
Published: (2022-06-01)

New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report
by: Himani T Chaturvedi, et al.
Published: (2023-01-01)

Fetal Surveillance in Pregnancies with Myasthenia Gravis
by: Brîndușa Ana Cimpoca-Raptis, et al.
Published: (2021-11-01)

Significance of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization and Presence of Thyroid Autoimmune Antibodies and Thymoma [Corrigendum]
by: Supawongwattana M, et al.
Published: (2024-02-01)

Myasthenia gravis and related disorders : 11th International Conference /
by: Kaminski, Henry J., et al.
Published: (2008)

Clinical signs in neuro-ophthalmology: Eye signs in myasthenia gravis
by: Sui Hsien Wong
Published: (2022-01-01)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
by: Cao, M
Published: (2021)

Physiotherapy in myasthenia gravis
by: Klaudia Kwiatkowska, et al.
Published: (2018-12-01)

Clinical characteristics of late-onset myasthenia gravis
by: Chenjing Sun, et al.
Published: (2024-04-01)

Early onset of ocular autoimmune myasthenia - case report
by: Raluca Ioana Teleanu, et al.
Published: (2013-06-01)

Novel Immunotherapies for Myasthenia Gravis
by: Nair SS, et al.
Published: (2023-04-01)

Significance of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization and Presence of Thyroid Autoimmune Antibodies and Thymoma
by: Supawongwattana M, et al.
Published: (2023-02-01)

A controlled clinical study on efficacy and safety of periocular triamcinolone acetonide injection for treating ocular myasthenia gravis
by: Minghua Shi, et al.
Published: (2024-01-01)

An angel or a devil? Current view on the role of CD8+ T cells in the pathogenesis of myasthenia gravis
by: Yong Peng, et al.
Published: (2024-02-01)

Generalized Myasthenia Gravis Diagnosed After Blepharoplasty
by: Murat Alemdar, et al.
Published: (2021-12-01)

Национален консенсус за диагностика и лечение на myasthenia gravis
by: Ivan Milanov, et al.
Published: (2021-03-01)

Национален консенсус за диагностика и лечение на myasthenia gravis
by: Ivan Milanov, et al.
Published: (2023-04-01)

Uncontrolled recurrent myasthenia gravis exacerbations secondary to chronic gabapentin use
by: Jason L. Chien, et al.
Published: (2019-07-01)

Effect of Thymectomy in Myasthenia Gravis
by: Tuncay Gündüz
Published: (2016-12-01)

Minimal Manifestation Status Indicates a Stable State in Myasthenia Gravis: A Quantitative Study
by: Ping Jiang, et al.
Published: (2022-05-01)

Altered serum levels of cytokines in patients with myasthenia gravis
by: Shu-Li Wei, et al.
Published: (2024-01-01)

Role of thymus on prognosis of myasthenia gravis in Turkish population
by: Hulya Tireli, et al.
Published: (2020-10-01)

Clinical characteristics and outcomes of COVID-19 infection among myasthenia gravis patients in a national referral hospital in Indonesia
by: Fitri Octaviana, et al.
Published: (2023-09-01)

Oral function in patients with myasthenia gravis
by: Agnete Overgaard Donskov, et al.
Published: (2021-06-01)

Trigeminal neuralgia in an elderly male patient with serologically proven myasthenia gravis: Co-occurrence or causation?
by: Divij Sharma, et al.
Published: (2023-04-01)

Severity and antibodies profile of seropositive myasthenia gravis
by: Amal M Alkhotani, et al.
Published: (2023-01-01)

New‐Onset Myasthenia Gravis Mimics Spinal Cord Injury After Zenker's Diverticulum Repair
by: Steffen E. Meiler, et al.
Published: (2023-04-01)

Successful use of sugammadex for caesarean section in a patient with myasthenia gravis
by: Lokman Soyoral, et al.

Recombinant Acetylcholine Receptor Immunization Induces a Robust Model of Experimental Autoimmune Myasthenia Gravis in Mice
by: Lukas Theissen, et al.
Published: (2024-03-01)

Refractory generalized myasthenia gravis with myasthenic incomplete ophthalmoplegia successfully treated with eculizumab
by: Sara L. Weidmayer, et al.
Published: (2023-12-01)

Thymic carcinoma with myasthenia gravis：A case report
by: Zheng-Hong Wang, et al.
Published: (2023-06-01)

Intensive care management of myasthenia gravis after thymectomy
by: Fidelis A Onyekwulu, et al.
Published: (2008-01-01)

Epidemiology of myasthenia gravis in the United States
by: Yun Ye, et al.
Published: (2024-02-01)

Lyme hastalığı ve myasthenia gravis
by: Ahmet EVLİCE, et al.
Published: (2018-12-01)

Medical treatment for myasthenia gravis at a Myasthenia Center
by: Tatyana Valentinovna Romanova
Published: (2013-12-01)

EPIDEMIOLOGICAL FEATURES OF MYASTHENIA GRAVIS
by: Yu. A. KHATKHE, et al.
Published: (2018-02-01)